| 股號 / 名稱 | 總負債 | 淨值 |
| MDT 美敦力 | 1,348,688,353,340.37 | 1,536,967,054,436.77 |
| NVO 諾和諾德 | 1,733,519,009,131.86 | 964,252,090,883.06 |
| SYK 史賽克 | 803,153,975,952.16 | 708,256,456,137.8 |
| ZBH Zimmer Biomet Holdings Inc | 339,012,228,324.83 | 402,982,760,157.09 |
| PHG Koninklijke Philips NV | 585,284,795,869.54 | 391,203,215,684.76 |
| BIO Bio Rad Laboratories Inc | 93,494,906,671.96 | 212,818,113,011.11 |
| RMD 瑞思邁 | 68,945,733,327.95 | 199,679,008,038.17 |
| NVST Envista Holdings Corp | 80,691,323,189.69 | 97,557,430,323.14 |
| ICUI ICU Medical Inc | 62,411,419,917.16 | 67,200,648,809.95 |
| NEOG Neogen Corp | 39,660,624,072.48 | 66,481,588,441.77 |
| QDEL QuidelOrtho Corp | 114,947,937,865.68 | 64,330,662,233.68 |
| EYE National Vision Holdings Inc | 34,740,295,077.42 | 27,128,591,549.03 |
| INMD Inmode Ltd | 2,565,771,158.23 | 20,640,684,415.41 |
| TGTX TG Therapeutics Inc | 13,198,652,850.72 | 19,182,251,060.8 |
| ATRC AtriCure Inc | 5,020,818,013.21 | 15,053,040,104.59 |
| WRBY Warby Parker Inc | 10,655,310,866.61 | 11,676,596,458.52 |
| BLFS BioLife Solutions Inc | 1,211,238,583.46 | 11,174,751,585.09 |
| QTRX Quanterix Corp | 4,094,303,579.58 | 9,936,250,498.43 |
| PAHC Phibro Animal Health Corp | 33,923,114,970.04 | 9,846,123,126.92 |
| MRVI Maravai LifeSciences Holdings Inc | 19,072,632,421.07 | 7,753,639,133.09 |
| ORMP Oramed Pharmaceuticals Inc | 543,702,134.99 | 6,421,756,865.15 |
| VALN Valneva SE | 11,038,811,588.0 | 5,578,761,020.34 |
| VMD Viemed Healthcare Inc | 2,171,902,224.46 | 4,220,728,304.71 |
| UTMD Utah Medical Products Inc | 117,611,007.41 | 3,735,626,335.91 |
| CAPR Capricor Therapeutics Inc | 1,344,832,746.72 | 2,649,399,123.71 |
| MGNX MacroGenics Inc | 6,436,920,250.47 | 2,116,587,458.42 |
| CERS Cerus Corp | 4,856,137,330.53 | 1,941,639,900.25 |
| INFU InfuSystem Holdings Inc | 1,371,338,660.17 | 1,752,350,306.8 |
| ZVIA Zevia PBC | 276,700,191.76 | 1,619,007,287.11 |
| RMTI Rockwell Medical Inc | 646,528,841.72 | 1,169,476,093.05 |
| ICCC ImmuCell Corp | 503,212,105.34 | 941,420,041.41 |
| VERU Veru Inc | 363,385,790.71 | 579,136,123.36 |
| XGN Exagen Inc | 1,411,616,402.43 | 572,986,422.9 |
| MYO Myomo Inc | 614,491,451.66 | 462,027,718.99 |
| SNES Senestech Inc | 103,490,104.83 | 358,487,701.35 |
| UG United-Guardian Inc | 50,478,593.84 | 334,303,365.37 |
| PHGE Biomx Inc | 495,400,434.66 | 331,256,788.54 |
| NEPH Nephros Inc | 102,384,441.32 | 316,093,403.22 |
| CLRB Cellectar Biosciences Inc | 165,794,559.7 | 296,296,655.97 |
| CTSO Cytosorbents Corp | 1,160,314,881.09 | 284,945,282.53 |
| APYX Apyx Medical Inc | 1,627,441,920.2 | 184,740,577.85 |
| IMCC IM Cannabis Corp | 916,474,435.57 | 89,969,733.91 |
| GCTK GlucoTrack Inc | 174,979,148.55 | 86,905,152.13 |
| EOLS Evolus Inc | 7,826,739,286.5 | -908,539,503.95 |
| OMER Omeros Corp | 12,831,509,383.58 | -6,964,985,144.35 |
| BRBR Bellring Brands Inc | 49,628,496,547.39 | -16,133,210,176.16 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例